Approval · Notice of Compliance 3471 · 2003
ELIDEL: Notice of Compliance 3471
Issued March 19, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3471
- Date
- March 19, 2003
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Ascomycin macrolactam derivative
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELIDEL | 02247238 | Marketed |
Medicinal ingredients
- PIMECROLIMUS 1 PER